Evaluation of a platinum-doxorubicin complex in experimental tumor systems Franco ZuninoGraziella PratesiAlessandro Pasini Preclinical Studies Pages: 341 - 345
A semi-automated neutral red based chemosensitivity assay for drug screening Paul F. Cavanaugh Jr.Patricia S. MoskwaAngelo P. Andrese Preclinical Studies Pages: 347 - 354
Fluorinated anthracyclines: interactions with DNA Ken C. TonkinRay C. BostonDon R. Phillips Preclinical Studies Pages: 355 - 363
Tolerance of full dose menogaril (NSC 269148) in patients with abnormal hepatic and renal function Barbara A. ConleyMerrill J. EgorinDavid A. Van Echo Brief Report Pages: 365 - 367
3-Deazaguanine: Report of a phase I trial and drug-related cardiac toxicity Kim MargolinJames DoroshowDavid Goldberg Clinical Studies Pages: 369 - 376
Phase II trial of vinblastine in advanced ovarian carcinoma Gregory P. SuttonJohn A. BlessingParviz Hanjani Clinical Studies Pages: 377 - 379
Phase II trial of echinomycin in advanced soft tissue sarcomas Sarah A. TaylorBarbara MetchKarl H. Hanson Clinical Studies Pages: 381 - 383
Phase II study of carbetimer in non-small cell lung cancer M. KeatonT. BrownD. Von Hoff Brief Report Pages: 385 - 386
Trimetrexate in locally advanced or metastatic adenocarcinoma of the pancreas Robert W. CarlsonJames H. DoroshowKathleen R. Lamborn Brief Report Pages: 387 - 389
Phase II trial of Didemnin B in patients with advanced renal cell carcinoma Robert MotzerHoward ScherGeorge J. Bosl Clinical Studies Pages: 391 - 392
4′ -epi-doxorubicin in advanced lung cancer Giuseppe GiacconeMichela DonadioAlessandro Calciati Clinical Studies Pages: 393 - 396
Phase II study of ionidamine in patients with metastatic breast cancer H. Ian RobinsDonna S. NeubergDouglass C. Tormey Brief Report Pages: 397 - 399
Aziridinylbenzoquinone (AZQ) in the treatment of recurrent pediatric brain and other malignant solid tumors R. P. CastleberryA. H. RagabJ. P. Krischer Clinical Studies Pages: 401 - 406
High versus low dose granisetron, a selective 5HT3 antagonist, for the prevention of chemotherapy-induced nausea and vomiting H. C. FalksonC. I. FalksonG. Falkson Brief Report Pages: 407 - 409